Safety monitoring for disease-modifying anti-rheumatic drugs in primary and secondary care: adherence to local and national guidelines and patients' views.
Kay
L J
LJ
Lapworth
K
K
D018501:Antirheumatic Agents / Q000009:adverse effects*; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D008297:Male; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D011358:Product Surveillance, Postmarketing
D018501:Antirheumatic Agents